641
2
2
2
1.
2.
3.
Ebisu T, RooneyWD, Graham SH, et al: -acetylaspartate as an
in vivo marker of neuronal viability in kainate-induced status
epilepticus:
43. DucCO, WeberAH,TrabesingerAH, et al: Recyclingthecholines,
abstract. Int SocMagnResonMed 1997;6:1210.
1H
magneticresonancespectroscopicimaging.
J
Cereb
44.
WurtmanRJ: Cholineand
neurons. Sci-
BlusztajnJK,
ence
cholinergic
BloodFlowMetab 1994; 14:373-382.
1
983;221:614-620.
BarthaR, Stein MB, WilliamsonPC, et al:
A
short echo 1Hspec-
Loffelholz K:
ofcholine
45.
Receptorregulation
phospholipidhydrol-
troscopy and volumetric MRI study of the corpus striatum in
patients with obsessive compulsive disorder and comparison
A
novelsourceof diaglycerolandphosphatidicacid.Biochem
P1 9h8 9a; 3r8 :m1 5 a4 3 c- 1 o5 4 l9 .
ysis.
subjects. Am
J
Psychiatry 1998;155:1584-1591.
46. Ross
B,
MichaelisT:
Clinicalapplications ofmagnetic
resonance
be the
Ebert D, SpeckO, Konig A, et al: 1-H-magnetic resonance spec-
troscopy in obsessive-compulsive disorder: Evidence
ronal lossinthecingulategyrusandtherightstriatum. Psychiatry
Res 1997; 74:173-176.
spectroscopy. MagnReson
Vion-DuryJ, MeyeroffDJ,
Q
1994;10:191-247.
Cozzone
et al: What
for neu-
47.
48.
PJ,
might
impactonneurobiologyoftheanalysisofbrainmetabolismbyin
vivomagnetic
resonancespectroscopy?
J1 994 ;N2 4e1 :u3 5 r4 - o3 7 l1 .
2
2
4.
5.
DR,MacMasterFP, KeshavanM, etal: Decreaseincau-
Rosenberg
Kato
Inubushi
Kato N:
resonance
in
T,
T,
Magnetic
Neuropsychiatry
spectroscopy
Clin Neurosci
date
concentrations in pediatric obsessive com-
glutamatergic
affective disorders.
133-147.
J
1998;10:
pulsive disorder patients taking paroxetine.
JAmAcad Child
AdolescPsychiatry 2000;39:1096-1103.
4
9. Exton JH: Hormonal regulation of phosphatidylcholine break-
Fitzgerald KD, Moore GJ, Paulson LD, et al: Priority communi-
cation. Protonspectroscopicimagingofthethalamusintreatment-
naive pediatric obsessive compulsivedisorder. BiolPsychiatry
down. Adv Second Messenger Phosphoprotein Res 1990;24:
152-157.
5
5
5
0. ExtonJH: Phosphatidylcholine breakdownandsignal transduc-
tion. BiochemBiophysActa 1994;1212:26-42.
2
000;47:174-182.
2
6. AmericanPsychiatricAssociation: DSM-IV:DiagnosticandSta-
tistical Manual ofMental Disorders, 4th ed. Washington, DC,
AmericanPsychiatric Press, 1994.
1.
Ziesel SH: Choline phospholipids: Signal transduction and car-
cinogenesis. FASEB
1993;7:551-557.
2. DawsonRM, Hemington N, Irvine RF: The inhibition of diacyl-
intracellular phospholipases by phospho-
J
2
7. KaufmanJ, BirmaherB, BrentD, etal: ScheduleforAffectiveDis-
orders and Schizophrenia for School-Age Children-Present and
LifetimeVersion(K-SADS-PL): Initial reliablilityandvaliditydata.
JAm AcadChildAdolescPsychiatry 1997;36:980-988.
glycerol-stimulated
lipids with
phosphocholine-containingpolargroup.
for
a
A
possible
physiologicalrole
1985;230:61-68.
sphingomyelin.
BiochemJ
5
5
3. AlsobrookJP, Pauls DL: Molecular approachesto child psycho-
2
2
3
3
8.
ScahillL, RiddleMA,McSwiggin-HardinM, et al: Children’sYale-
BrownObsessiveCompulsiveScale: Reliabilityandvalidity. JAm
AcadChildAdolescPsychiatry 1997;36:844-852.
HumBiol 1998;70:413-432.
pathology.
4. BodkinJA, White K: Clonazepam in the treatment ofobsessive
withpanicdisorderinonepatient.
compulsivedisorderassociated
ClinPsychiatry 1989;50:265-266.
9. Duyn JH, Moonen CT: Fast proton spectroscopic imaging of
J
humanbrainusingmultiple spin-echoes.MagnResonMed1993;30:
5
5
5.
GehrisTL, KatholRG,BlackDW,etal: Urinaryfree cortisollevels
4
09-414.
in obsessive-compulsivedisorder. PsychiatryRes1990;32:151-158.
0.
SoherBJ, HurdRE, SailasutaN, BarkerPB: Quantitationofauto-
mated
protonMRSusingcerebral waterat aninter-
6. LeckmanJF, GoodmanWK, NorthWG, et al: Therole ofcentral
single-voxel
nal reference. MagnResonMed1996;36:335-339.
oxytocin in
obsessive compulsive disorder and related normal
behavior. Psychoneuroendocrinology 1994; 19:723-749.
1. DanielsDL, HaughtonVM,NaidichTP: CranialandSpinalMag-
neticResonanceImaging:AnAtlasandGuide. NewYork, Raven,
5
7. MonteleoneP, CatapanoF, DelBuonoG, Maj M: Circadianrhythms
of melatonin, cortisol andprolactinin
patientswithobsessive-com-
1987.
pulsive disorder.
ActaPsychiatrScand 1994;89:411-415.
3
3
2. Talairach J, Tournoux P: Co-planar Stereotaxic Atlas of the
HumanBrain. NewYork, Thieme, 1988.
58. Monteleone P, Catapano F, TortorellaA, et al: Plasmamelatonin
and cortisol circadian patterns in patients with obsessive-com-
3.
NolteJ, Farrell R: TheHumanBrain:AnIntroductionto ItsFunc-
tionalAnatomy:OlfactoryandLimbicSystems. St. Louis, Mosby-
YearBook, 1993, 397-413.
disorder before andafter fluoxetine treatment. Psycho-
pulsive
neuroendocrinology 1995;20:763-770.
PortasCM, GoldsteinJM, Shenton ME, et al: Volumetric evalua-
tionofthethalamusin schizophrenicmalepatientsusingmagnetic
resonance imaging. BiolPsychiatry 1998;43:649-659.
5
9. Monteleone P, Catapano F, Tortorella A, et al: Cortisol response
3
3
3
3
4.
to d-fenfluramine inpatientswithobsessive-compulsivedisorder
and in healthy subjects: Evidence for
Neuropsychobiology 1997;36:8-12.
a
gender-related effect.
5. BuchsbaumMS, SomeyaT, TengCY, etal: PETandMRIofthethal-
amusinnever-medicatedpatientswithschizophrenia.AmJ Psy-
60. SwedoSE, LeonardHL, KruesiMJP, et al: Cerebrospinalfluidneu-
in children andadolescentswithobsessive-compul-
rochemistry
chiatry 1996;153:191-199.
sive disorder. Arch GenPsychiatry 1992;49:29-36.
6. Andreasen NC, ArndtS, SwayzeV, etal: Thalamicabnormalities
in schizophrenicsvisualized throughmagnetic resonance image
61.
Khiat A, Bard C, Lacroix A, et al: Brain metabolic alterations in
Science 1994;266:294-298.
Cushing’s syndromeasmonitoredbyprotonmagneticresonance
averaging.
spectroscopy.
NuclMagnResonBiomed 1999;12:357-363.
7.
B: Thevolumeofthe mediodorsalthalamic nucleus
Pakkenberg
in treated and untreated schizophrenics. SchizophrRes 1992;7:
62. GuptaRK, BhatiaV, PoptaniH, GujralRB: Brainmetabolicchanges
9
5-100.
onin vivo proton magnetic resonance spectroscopy in children
Staal WG, Hulshoff Pol HE, Schnack H, et al: Partial volume
decrease of the thalamus in relatives of patients with schizo-
with congenital hypothyroidism. J
Pediatr 1995;126:389-392.
3
3
8.
9.
63. BhataraVS, TripathiRP, SankarR, etal: Frontallobeprotonmag-
Am
J
Psychiatry 1998;155:1784-1786.
neticresonancespectroscopyinGraves’ disease:
choneuroendocrinology 1998;23:605-612.
A
pilotstudy.Psy-
phrenia.
HetheringtonHP, MasonGF, PanJW, et al: Evaluationofcerebral
and white matter metabolite differences by spectroscopic
64. MooreCM, BreezeJL, GruberSA, etal: Myoinositol, choline and
gray
imagingat 4.1T.
MagnResonMed1994;32:565-571.
moodin bipolar disorder:
A
proton MRSIstudy ofanterior cin-
4
4
0. MooreGJ: Protonmagneticresonancespectroscopyin pediatric
gulate cortex. BipolarDisord 2000;2:207-216.
neuroradiology.
P
1
e
9
d
9
i
8
a
;2
t
8
r
:8
R
0
a
5-
d
8
i
1
o
4
l
.
65. RenshawPF, Lafer B, Babb SM, et al: Basal ganglia choline lev-
1.
Barker P, Breiter S, Soher B, et al: Quantitative proton spec-
els in depression and response to fluoxetine treatment: An in
ofcanine brain: Invivoandinvitro correlations. Magn
troscopy
vivo proton magnetic resonance spectroscopy
chiatry 1997;41:837-843.
sB t iu do y l.
Psy-
ResonMed 1994;32:157-163.
4
2.
Miller BL, Chang L, Booth R, et al: In vivo 1H MRS choline:
66.
Steingard RJ, Yurgelun-Todd DA, Hennen J, et al: Increased
orbitofrontalcortexlevels ofcholine indepressedadolescentsas
detectedbyinvivoprotonBiol Psychiatry2000;1:1053-1061.
Correlation with in vitro chemistry/histology. Life Sci 1996;58:
1
929-1935.